Metabolic syndrome and the immunogenicity of Pfizer–BioNTech vaccine: a cross-sectional study in Japanese healthcare workers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-5996
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Metabolic syndrome and the immunogenicity of Pfizer–BioNTech vaccine: a cross-sectional study in Japanese healthcare workers ; volume:14 ; number:1 ; day:13 ; month:10 ; year:2022 ; pages:1-7 ; date:12.2022
Diabetology & metabolic syndrome ; 14, Heft 1 (13.10.2022), 1-7, 12.2022
- Creator
-
Hoang, Dong Van
Yamamoto, Shohei
Fukunaga, Ami
Inoue, Yosuke
Mizoue, Tetsuya
Ohmagari, Norio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13098-022-00918-6
- URN
-
urn:nbn:de:101:1-2022123020592630062333
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hoang, Dong Van
- Yamamoto, Shohei
- Fukunaga, Ami
- Inoue, Yosuke
- Mizoue, Tetsuya
- Ohmagari, Norio
- SpringerLink (Online service)
Other Objects (12)
Impfstoff Pfizer-BioNTech COVID-19 Vaccine
CD11c-specific bio-nanocapsule enhances vaccine immunogenicity by targeting immune cells
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)
Herpetic anterior uveitis following Pfizer–BioNTech coronavirus disease 2019 vaccine: two case reports
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community
Immunogenicity of infectious pathogens and vaccine antigens
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
Immunogenicity of two different hepatitis B vaccine schedules
Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA
Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals
Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)
Impfstoff Pfizer-BioNTech COVID-19 Vaccine
CD11c-specific bio-nanocapsule enhances vaccine immunogenicity by targeting immune cells
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)
Herpetic anterior uveitis following Pfizer–BioNTech coronavirus disease 2019 vaccine: two case reports
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community
Immunogenicity of infectious pathogens and vaccine antigens
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
Immunogenicity of two different hepatitis B vaccine schedules
Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA
Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals
Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)
Impfstoff Pfizer-BioNTech COVID-19 Vaccine
CD11c-specific bio-nanocapsule enhances vaccine immunogenicity by targeting immune cells
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)
Herpetic anterior uveitis following Pfizer–BioNTech coronavirus disease 2019 vaccine: two case reports
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community
Immunogenicity of infectious pathogens and vaccine antigens
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
Immunogenicity of two different hepatitis B vaccine schedules
Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA
Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals